Mark Orlando
Neurology · Weston, FLNPI 1699345850
Payments from drug & device makers
Across 100 payments — averaging $32.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$572
- UCB, Inc.$413
- AstraZeneca$354
- Argenx US, Inc.$330
- Eisai Inc.$190
- EMD Serono, Inc.$173
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,269100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $572 |
| UCB, Inc. | 12 | $413 |
| AstraZeneca | 12 | $354 |
| Argenx US, Inc. | 5 | $330 |
| Eisai Inc. | 5 | $190 |
| EMD Serono, Inc. | 4 | $173 |
| Merz Pharmaceuticals, LLC | 4 | $164 |
| Genentech USA, Inc. | 2 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $142 |
| Novartis | 5 | $97 |
| Neurelis, Inc. | 4 | $85 |
| Medtronic | 2 | $79 |
| GSK | 1 | $70 |
| Amgen | 1 | $69 |
| TG Therapeutics, Inc. | 2 | $54 |
| Neurocrine Biosciences, Inc. | 3 | $48 |
| Novo Nordisk | 2 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $42 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Livanova USA, Inc. | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$125
- VYVGART HYTRULO$125
- VYVGART$120
- XEOMIN$107
- Leqembi$107
How this compares
$3,269 in reported general payments places this provider in the 50th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 23 | $316 |
| Donepezil Hcl | 20 | $205 |
| Atorvastatin Calcium | 15 | $174 |
Paid to pharmacies, not to this prescriber.
Other neurology in Weston
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
- Rekha GandhiWinter Park$13.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.